Articles On Micro-X (ASX:MX1)

Title Source Codes Date
Micro-X posts strong quarterly results as coronavirus boosts x-ray sales

X-ray technology company Micro-X (ASX: MX1) has posted stronger-than-expected first quarter results as orders for its mobile x-ray system grow “substantially” in response to coronavirus-stimulated demand. The company said the rapidly growin...

SmallCaps MX1 4 years ago
10 at 10: These ASX stocks are shining bright this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead MX1 4 years ago
Coronavirus has turned into a money spinner for an ASX-listed mobile x-ray tech company

Coronavirus continues to drive sales into Asia and Europe for South Australian hi-tech x-ray manufacturer Micro-X. The Adelaide-based company reported to the ASX last week that sales of its flagship lightweight mobile x-ray machine had reac...

Startup Daily MX1 4 years ago
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

Stockhead MX1 4 years ago
Coronavirus prompts more orders for Micro-X’s mobile x-ray units

Micro-X (ASX: MX1) has collared an additional $1 million in sales for its mobile x-ray technology as governments worldwide scramble to get on top of the coronavirus COVID-19 outbreak. The additional $1 million order follows purchase orders...

SmallCaps MX1 4 years ago
Health: Cogstate continues recovery, makes $9m in sales

Neuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it has executed $9.1m of clinical trials sales contracts since the start of 2020. The stock — up about 30 per cent on the news — says this revenu...

Stockhead MX1 4 years ago
9 of the most interesting biotech bosses in the game: part 2

You don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the most complicated mysteries still to be solved today: the human body. Biotech CEOs and chairs tend to be the cross-over scientists. However,...

Stockhead MX1 5 years ago
Dr Boreham’s Crucible: Memphasys now feeling the investor love for its IVF tech

Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...

Stockhead MX1 5 years ago
Micro-X hones in on equity raising

Stockbroker Morgans is expected to close the books on an equity raising for lightweight X-ray products maker Micro-X.

AFR MX1 5 years ago
Micro-X Ltd to amend its Loan Agreement with Thales

Australian high-tech company Micro-X Ltd (ASX: MX1) has informed that it is amending the Convertible Loan Agreement with Thales AVS France SAS completed on the 2 July 2019 so that the convertible security under the Loan Agreement does not t...

Kalkine Media MX1 5 years ago
Are These Stocks Anywhere Close to Becoming Health Care Stars – Biotron, Micro-X

In Australia, there are plenty of high-quality health care companies, most of which have delivered excellent returns. Investment in health care stocks is high yielding; however, it does include risks. If undergoing clinical studies fail to...

Kalkine Media MX1 5 years ago
Here’s how South Australians and their small caps are trying to put themselves on the map

People in Sydney and Melbourne might think of Adelaide as home to little more than football, wines and an electricity network that isn’t always up to scratch. But as Lanyon Asset Management managing director David Prescott noted, the world’...

Stockhead MX1 5 years ago
7 Health Care Stocks With Quarterly Update – ZLD, MX1, SVA, CGS, BNO, TLX And OSL

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in th...

Kalkine Media MX1 5 years ago
Australia’s top biotechs descend on Queenstown for the 2019 Bioshares Summit

Queenstown is known as the adventure capital of the world. It attracts over three million people per year to experience the world-class ski runs, zip-line riding, white water rafting, sky diving and is, of course, famous for manufacturing t...

FinFeed MX1 5 years ago
Would you Invest In These Six Stocks- CPV, MX1, SEN, JAY, FGR and PRZ?

Business magnate Warren Buffet advised the investors to absolutely refrain from investing in a business that they are unable to understand. This would resonate with the mind and willingness of every active investor, as they all practice the...

Kalkine Media MX1 5 years ago